Login/Sign Up
Amfosted 500 Injection 1's belongs to the class of cytoprotective agents. It is used in reducing cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer. It is also used for the reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.
Amfosted 500 Injection 1's contains Amifostine, which belongs to the class of protective agents. It works by protecting the kidneys in patients undergoing chemotherapy and radiation therapy.
Amfosted 500 Injection 1's may cause certain side effects such as nausea, vomiting, pain at the site of injection, and injection site reactions. Inform your doctor if any of these side effects persist for longer. Amfosted 500 Injection 1's will be administered by your physician in the hospital. Do not self-administer.
Avoid receiving Amfosted 500 Injection 1's and inform your doctor if you are allergic to it or any other components of it. Before taking Amfosted 500 Injection 1's, tell your doctor if you have/had liver or kidney disease, cardiac problems, skin disorders, and low calcium levels. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. Avoid breastfeeding while taking this Amfosted 500 Injection 1's.
Amfosted 500 Injection 1's contains Amifostine, which is used in protecting kidneys from renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer. It is a cytotoxic medicine that detoxifies the reactive metabolites of platinum and alkylating agents.
To treat your condition effectually, continue receiving Amfosted 500 Injection 1's for the period that your doctor has prescribed. Amfosted 500 Injection 1's may cause severe cutaneous reactions, hypotension, cardiovascular problems, nausea, vomiting, and hypocalcemia. Therefore, caution should be exercised if you have/had liver or kidney disease, heart problems, and skin disorders while receiving Amfosted 500 Injection 1's. This medicine may also cause severe hypersensitivity reactions. Hence, careful monitoring is recommended and discontinue the treatment if any severe allergic reactions occur. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. This medicine is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions: Amfosted 500 Injection 1's may have interaction with antihypertensive drugs, calcimimetic drugs (etelcalcetide),
Drug-Food Interactions: No interactions found.
Dug-Disease Interactions: Tell your doctor if you have kidney disease, heart problems, hypotension, skin disorders, or hypocalcaemia before starting the treatment.
Ovarian cancer: It is a common type of cancer that occurs when abnormal cells in the ovary begin to multiply out of control and form a tumor. If left untreated, the tumor can spread to other parts of the body (metastasis). This is called metastatic ovarian cancer. Symptoms may include abdominal bloating, pressure, pain, abnormal fullness after eating, difficulty eating, increased urination, and an increased urge to urinate.
About Amfosted 500 Injection 1's
Amfosted 500 Injection 1's belongs to the class of cytoprotective agents. It is used in reducing cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer. It is also used for the reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.
Amfosted 500 Injection 1's contains Amifostine, which belongs to the class of protective agents. It works by protecting the kidneys in patients undergoing chemotherapy and radiation therapy.
Amfosted 500 Injection 1's may cause certain side effects such as nausea, vomiting, pain at the site of injection, and injection site reactions. Inform your doctor if any of these side effects persist for longer. Amfosted 500 Injection 1's will be administered by your physician in the hospital. Do not self-administer.
Avoid receiving Amfosted 500 Injection 1's and inform your doctor if you are allergic to it or any other components of it. Before taking Amfosted 500 Injection 1's, tell your doctor if you have/had liver or kidney disease, cardiac problems, skin disorders, and low calcium levels. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. Avoid breastfeeding while taking this Amfosted 500 Injection 1's.
₹3726.9*
MRP ₹4545
18% off
₹3863.25*
MRP ₹4545
15% CB
₹681.75 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of Amfosted 500 Injection 1's
Medicinal Benefits
Amfosted 500 Injection 1's contains Amifostine, which is used in protecting kidneys from renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer. It is a cytotoxic medicine that detoxifies the reactive metabolites of platinum and alkylating agents.
Side Effects of Amfosted 500 Injection 1's
Directions for Use
Storage
Drug Warnings
To treat your condition effectually, continue receiving Amfosted 500 Injection 1's for the period that your doctor has prescribed. Amfosted 500 Injection 1's may cause severe cutaneous reactions, hypotension, cardiovascular problems, nausea, vomiting, and hypocalcemia. Therefore, caution should be exercised if you have/had liver or kidney disease, heart problems, and skin disorders while receiving Amfosted 500 Injection 1's. This medicine may also cause severe hypersensitivity reactions. Hence, careful monitoring is recommended and discontinue the treatment if any severe allergic reactions occur. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. This medicine is not recommended for use in children as the safety and efficacy are not established.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Ovarian cancer: It is a common type of cancer that occurs when abnormal cells in the ovary begin to multiply out of control and form a tumor. If left untreated, the tumor can spread to other parts of the body (metastasis). This is called metastatic ovarian cancer. Symptoms may include abdominal bloating, pressure, pain, abnormal fullness after eating, difficulty eating, increased urination, and an increased urge to urinate.